{"disease":{"id":"crohn-39-s-disease-cd","name":"crohn 39 s disease cd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07123350","title":"Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT07010926","title":"A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"L2 Bio, LLC","has_results":false},{"nct_id":"NCT06895772","title":"Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT06922331","title":"Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis","phase":"","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT07113431","title":"Partial-enteral Nutrition Protocol for Crohn's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Kate Farms Inc","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}